drugset / Trial / NCT03307993
Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease
NaSingle-groupOpen-labelTreatment
Summary
To investigate the brain receptor occupancy of idalopirdine in patients with Alzheimer's disease (AD)
Timeline
- Start
- 2017-09-22
- Primary completion
- 2018-02-19
- Completion
- 2018-02-19
Outcome
Outcome not reported
Stopped (Business): “The study was terminated for strategic reasons.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Idalopirdine | Small molecule | 60 mg | — |
| Subject | Idalopirdine | Small molecule | 120 mg | — |